Lake Bleu Capital is a Hong Kong-based investment platform that specializes in healthcare in Asia/Greater China. With a long-term investment horizon, we manage strategies through both public and private equity with a primary focus on mid- to late-stage investments.
Lake Bleu Capital holds Hong Kong SFC-issued Type 9 (asset management) license and provides services only to professional investors.
Founded in 2017, BioTrack Capital is a dedicated healthcare venture capital firm focused on investing and incubating innovative life science companies in China. We are more than just capital providers. We invest in long-term partnerships with China’s leading healthcare entrepreneurs to build the next generation of world class companies.